ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,627,000 | -8.7% | 26,388 | +7.9% | 0.08% | -13.3% |
| Q3 2019 | $1,783,000 | -19.8% | 24,461 | -9.5% | 0.09% | -18.2% |
| Q2 2019 | $2,223,000 | +4.7% | 27,041 | -10.2% | 0.11% | +10.0% |
| Q1 2019 | $2,124,000 | +46.3% | 30,105 | -6.6% | 0.10% | +35.1% |
| Q4 2018 | $1,452,000 | -24.4% | 32,244 | -5.1% | 0.07% | -5.1% |
| Q3 2018 | $1,921,000 | -13.0% | 33,974 | +2.8% | 0.08% | -19.6% |
| Q2 2018 | $2,207,000 | +4.3% | 33,035 | -9.1% | 0.10% | +2.1% |
| Q1 2018 | $2,116,000 | -10.8% | 36,347 | -1.2% | 0.10% | -7.8% |
| Q4 2017 | $2,372,000 | +1.5% | 36,805 | -17.3% | 0.10% | -4.6% |
| Q3 2017 | $2,336,000 | +16.9% | 44,505 | +4.2% | 0.11% | +14.9% |
| Q2 2017 | $1,999,000 | -4.7% | 42,720 | +0.8% | 0.09% | -4.1% |
| Q1 2017 | $2,098,000 | +14.1% | 42,379 | +39.7% | 0.10% | +12.6% |
| Q4 2016 | $1,839,000 | -5.3% | 30,337 | +3.6% | 0.09% | -6.5% |
| Q3 2016 | $1,942,000 | – | 29,270 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |